RSS-Feed abonnieren
DOI: 10.1055/a-2560-1560
Incidental Findings of Internal Mammary Lymph Node Recurrence after Breast Cancer during Microsurgical Breast Reconstruction: Discussion of Treatment Options and Review of the Literature
Zufallsbefunde von parasternalen Lymphknotenmetastasen im Rahmen einer sekundären mikrochirurgischen Brustrekonstruktion nach Mammakarzinom – Behandlungsoptionen und Darstellung der Literatur
Abstract
Background
Lymphatic drainage through the internal mammary lymph nodes (IMLN) is a key pathway for breast cancer metastasis, although IMLN metastasis is rare following primary treatment. In earlier years, treatment protocols primarily addressed axillary lymph node metastasis.
Patients and Methods
We present five cases where IMLN metastases were discovered incidentally during autologous free-flap breast reconstruction. These cases highlight implications for both the reconstructive plastic surgeon and subsequent adjuvant therapy.
Recommendations and Conclusion
From a plastic-reconstructive perspective, we recommend performing routine biopsies on any incidentally identified IMLN during autologous breast reconstruction. Positive findings may upstage the patient’s disease and influence further treatment planning. However, we do not recommend actively searching for or extending dissections to harvest IMLN specimens. Only in the presence of a suspicious perinodal tumour mass do we perform an intraoperative frozen-section analysis, with reconstruction paused if malignancy is confirmed. After complete staging and discussion in a multidisciplinary conference, we proceed with tumour resection according to oncological standards if curative resection is deemed feasible. Reconstruction can then be performed during the same procedure. For locoregional recurrence of breast cancer, treatment continues to be a multimodal approach involving surgery, radiation, and systemic therapy to ensure local control and optimise long-term survival. In primary treatment, current national and international guidelines now recommend locoregional irradiation of the internal mammary chain for high-risk cases, which may further reduce the incidence of incidental IMLN metastasis findings in the future.
Zusammenfassung
Hintergrund
Die lymphatische Drainage der Brustdrüse erfolgt vorwiegend über die Axilla. Der parasternale Lymphabfluss entlang der A. mammaria interna (IMLN) stellt jedoch ebenfalls einen wichtigen Drainageweg dar. Parasternale Lymphknotenmetastasen sind nach einer primären Systemtherapie des Mammakarzinoms selten. Früher wurden daher in Nachbehandlungsprotokollen regelhaft primär nur die axillären Lymphknoten adressiert.
Patienten und Methoden
Wir stellen 5 Fälle mit einem Zufallsbefund von parasternalen Lymphknotenmetastasen vor, die im Rahmen einer autologen sekundären Brustrekonstruktion mittels freier mikrochirurgischer Lappenplastik aufgefallen sind. Die Diagnose hat nicht nur einen direkten Einfluss für den operierenden rekonstruktiven Plastischen Chirurgen, sondern beeinflussen auch maßgeblich die anschließende adjuvante Therapie.
Empfehlung und Schlussfolgerung
Wir empfehlen jeden Lymphknoten der parasternalen Region, der im Rahmen der Präparation des Anschlussgefäßes einer autologen Brustrekonstruktion zufällig gefunden wird, histologisch zu untersuchen. Es wird jedoch nicht empfohlen explizit nach Lymphknoten zu suchen oder eine erweiterte Exploration anzustreben. Im Falle eines positiven Befundes, hat dies Auswirkungen auf die weitere onkologische Therapie. Das direkt intraoperative Vorgehen richtet sich hingegen nach der Ausdehnung des Befundes. Nur im Falle eines auffälligen Befundes erfolgt eine histopthologische Schnellschnittanalyse und Unterbrechung der Rekonstruktion bei positivem Befund. Wenn nach komplettem Staging in einer interdisziplinären Entscheidung die Resektion in kurativer Absicht möglich erscheint, erfolgt die Tumorresektion nach onkologischen Standards. Die Brustrekonstruktion führen wir dann in derselben Sitzung durch. Ein lokoregionäres Tumorrezidiv beeinflusst die Nachbehandlung als multimodalen Ansatz von Operation, Strahlentherapie und systemischer Behandlung. In den aktuellen nationalen und internationalen Leitlinien spiegelt sich das nun auch im Bereich der Primärtherapie des Mammakarzinoms wieder. Insbesondere die parasternale Lymphknotenreihe wurde nun ebenfalls Ansatzpunkt für eine lokoregionale Bestrahlung bei Hochrisikofällen, was das Risiko eines Lokalrezidives in der Zukunft reduzieren sollte.
Keywords
breast cancer recurrence - internal mammary lymph node - breast reconstruction - microsurgical free flapSchlüsselwörter
Rezidiv Mammakarzinom - parasternale Lymphknoten - mikrochirurgische freie Lappenplastik - Brustrekonstruktion - LymphknotenmetastasePublikationsverlauf
Eingereicht: 18. November 2024
Angenommen: 28. Februar 2025
Artikel online veröffentlicht:
14. April 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Bi Z, Chen P, Song XR. et al. The study of internal mammary lymph node dissection guided by modified radiotracer injection technique in breast cancer-a case report and review. Gland Surg 2020; 9: 430-436
- 2 Takuwa H, Tsuji W, Yamamoto Y. et al. Multidisciplinary treatment for locally advanced breast cancer with internal mammary lymph node metastasis in an elderly patient. Int Cancer Conf J 2019; 8: 1-6
- 3 Chen L, Gu Y, Leaw S. et al. Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer. BMC Cancer 2010; 10: 479
- 4 Lamonica D, Edge SB, Hurd T. et al. Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures. Clin Nucl Med 2003; 28: 558-564
- 5 Chaudhry IU, Algazal T, Alhajji Z. et al. Radical chest wall resection and modified reconstruction technique for solitary internal mammary lymph node recurrence in breast cancer. Int J Surg Case Rep 2019; 58: 26-29
- 6 Li L, Zhang H, Wang L. et al. A retrospective analysis on metastatic rate of the internal mammary lymph node and its clinical significance in adjuvant radiotherapy of breast cancer patients. BMC Cancer 2020; 20: 153
- 7 Zhang X, Jaffer S, Bleiweiss IJ. et al. The clinical significance of internal mammary lymph node (IMLN) biopsy during autologous reconstruction in breast cancer patients. Breast Cancer Res Treat 2015; 153: 565-572
- 8 Choi JE. et al. The Metastatic Rate of Internal Mammary Lymph Nodes When Metastasis of Internal Mammary Lymph Node Is Suspected on PET/CT. J Breast Cancer 2013; 16: 202-207
- 9 Chatzopoulos SE, Behranwala KA, Jayia P. et al. Should Internal Mammary Lymph Node Biopsy be A Routine Step in Recurrent Breast Cancer? Report of Three Cases With Negative Axilla and Positive Internal Mammary Node. World J Oncol 2011; 2: 311-313
- 10 Braue K, Baker C, Lippey J. Internal mammary node involvement in patients with axilla-negative early breast cancer: a narrative review. ANZ J Surg 2023; 93: 59-64 Epub 2022 Aug 23 35997283
- 11 Cranenbroek S, van der Sangen MJ, Kuijt GP. et al. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat 2005; 89: 271-275
- 12 van Geel AN, Wouters MW, van der Pol C. et al. Chest wall resection for internal mammary lymph node metastases of breast cancer. Breast. 2009; 18: 94-99
- 13 Qiu PF, Liu YB, Wang YS. Internal mammary sentinel lymph node biopsy: abandon or persist?. Onco Targets Ther 2016; 9: 3879-3882
- 14 Ochoa O, Azouz V, Santillan A. et al. Internal Mammary Lymph Node Biopsy During Free-Flap Breast Reconstruction: Optimizing Adjuvant Breast Cancer Treatment Through Comprehensive Staging. Ann Surg Oncol 2018; 25: 1322-1328
- 15 Schultz BD, Sultan D, Ha G. et al. Internal Mammary Lymph Node Biopsy during Microsurgical Breast Reconstruction: A Prospective Study. J Reconstr Microsurg. 2022. 38. 721-726 Epub 2022 Mar 15 35292953
- 16 Wright EJ, Momeni A, Kraneburg UM. et al. Clinical Significance of Internal Mammary Lymph Node Biopsy during Microsurgical Breast Reconstruction: Review of 264 Cases. Plast Reconstr Surg 2016; 137: 917e-922e
- 17 Heidekrueger PI, Moellhoff N, Horch RE. et al. Overall Complication Rates of DIEP Flap Breast Reconstructions in Germany-A Multi-Center Analysis Based on the DGPRÄC Prospective National Online Registry for Microsurgical Breast Reconstructions. 2021; 33801419 PMC7958631
- 18 Poortmans PM, Collette S, Kirkove C. et al. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med 2015; 373: 317-327
- 19 Chang JS, Park W, Kim YB. et al. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up. Int J Radiat Oncol Biol Phys 2013; 86: 867-872
- 20 Hammer J, Track C, Seewald DH. et al. Local relapse after breast-conserving surgery and radiotherapy: effects on survival parameters. Strahlenther Onkol 2009; 185: 431-437
- 21 Chen RC, Lin NU, Golshan M. et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review. J Clin Oncol 2008; 26: 4981-9 18711171
- 22 Poortmans PM, Weltens C, Fortpied C. et al Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Lancet Oncol 2020; 21: 1602-1610 Epub 2020 Nov 2 33152277
- 23 von Fritschen U, Seidenstücker K, Sigalove S. Current trends in postmastectomy breast reconstruction. Curr Opin Obstet Gynecol 2023; 35: 73-79 Epub 2022 Sep 21 36165007
- 24 Prantl L, Moellhoff N, von Fritschen U. et al. Effect of Radiation Therapy on Microsurgical Deep Inferior Epigastric Perforator Flap Breast Reconstructions: A Matched Cohort Analysis of 4577 Cases. Ann Plast Surg 2021; 86 (06) 627-631 33346536
- 25 ElAbd R, Jabori S, Willey B. et al. Outcomes of Immediate versus Delayed Autologous Reconstruction with Postmastectomy Radiation: A Meta-Analysis. 2024; 38315143
- 26 Friebel TR, Shanmugakrishnan RR, Zberea D. et al. Internal mammary perforator vessels as recipient for microvascular breast reconstruction: Technique and outcomes in 161 flaps. J Plast Reconstr Aesthet Surg. 2023. 85. 454-462 37586312
- 27 Poortmans PM, Struikmans H, Bartelink H. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med 2015; 373: 1879-1880
- 28 Urano M, Denewar FA, Murai T. et al. Internal mammary lymph node metastases in breast cancer: what should radiologists know? . Jpn J Radiol 2018; 36: 629-640
- 29 Andree C, Schmidt VJ, Munder BI. et al. Detecting of breast cancer metastasis by means of regional lymph node sampling during autologous breast reconstruction--a screening of 519 consecutive patients. Med Sci Monit 2012; 18: CR605-610
- 30 Karanetz I, Jin M, Nguyen K. et al Evaluation of internal mammary lymph node biopsy during microsurgical breast reconstruction: An analysis of 230 consecutive patient. Breast J 2021; 27: 7-12 Epub 2020 Dec 16
- 31 Grant AL, Lutz KH, Temple-Oberle CF. Incidental Internal Mammary Nodes during Recipient Vessel Dissection in Breast Reconstruction: Are They Significant?. Plast Reconstr Surg Glob Open 2015; 2 (12) e276 eCollection 2014 Dec
- 32 Coombs NJ, Boyages J, French JR. et al. Internal mammary sentinel nodes: ignore, irradiate or operate?. Eur J Cancer 2009; 45: 789-794
- 33 Huang O, Wang L, Shen K. et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 2008; 107: 379-387
- 34 Paredes P, Vidal-Sicart S, Zanon G. et al. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging 2005; 32: 1283-1287
- 35 Leidenius MH, Krogerus LA, Toivonen TS. et al. The clinical value of parasternal sentinel node biopsy in breast cancer. Ann Surg Oncol 2006; 13: 321-326
- 36 Wang K, Qiu P, Li J. Internal mammary lymph node metastasis in breast cancer patients based on anatomical imaging and functional imaging. Breast Cancer 2022; 29: 933-944 35750935 PMC9587969
- 37 Vinod SK, Pendlebury SC. Review of internal mammary chain irradiation in breast cancer. Breast. 1999; 8 (05) 245-50
- 38 Budach W, Bolke E, Kammers K. et al. Adjuvant radiation therapy of regional lymph nodes in breast cancer – a meta-analysis of randomized trials- an update. Radiat Oncol 2015; 10: 258
- 39 Kim KH, Noh JM, Kim YB. et al. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?. Breast Cancer Res Treat 2015; 152: 589-599
- 40 Sautter-Bihl ML, Sedlmayer F. [Internal mammary node irradiation in early node-positive breast cancer: Improved survival]. Strahlenther Onkol 2016; 192: 276-278
- 41 Verma V, Vicini F, Tendulkar RD. et al. Role of Internal Mammary Node Radiation as a Part of Modern Breast Cancer Radiation Therapy: A Systematic Review. Int J Radiat Oncol Biol Phys 2016; 95: 617-631
- 42 Recht A, Comen EA, Fine RE. et al. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. J Clin Oncol 2016; 34: 4431-4442
- 43 Poortmans P.. et al. Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate. Lancet 2014; 383: 2104-2106
- 44 Hjelstuen MH, Mjaaland I, Vikstrom J. et al. Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk. Acta Oncol 2012; 51: 333-344
- 45 Yu JT, Provenzano E, Forouhi P. et al. An evaluation of incidental metastases to internal mammary lymph nodes detected during microvascular abdominal free flap breast reconstruction. J Plast Reconstr Aesthet Surg 2011; 64: 716-721
- 46 Schaverien MV, Purdie CA, Munnoch DA. Clinical value of internal mammary lymph node metastases found incidentally during free flap recipient vessel exposure. Eur J Surg Oncol 2013; 39: 608-612
- 47 Dener C, Inan A, Sen M. et al. Interoperative frozen section for margin assessment in breast conserving energy. Scand J Surg 2009; 98: 34-40
- 48 Osako T, Nishimura R, Nishiyama Y. et al. Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer. Int J Clin Oncol 2015; 20: 1093-1101
- 49 Osborn JB, Keeney GL, Jakub JW. et al. Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins. Ann Surg Oncol 2011; 18: 3204-3209
- 50 AWMF. German interdisciplinary S3-guidelines for the early detection, diagnostics, therapy and follow-up of breast cancer (Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms), 02/2020. Online at https://www.awmf.org/uploads/tx_szleitlinien/032-045OLk_S3_Mammakarzinom_2020-02.pdf accessed 2021/05/22
- 51 Brautigam E, Track C, Seewald DH. et al. Medial tumor localization in breast cancer--an unappreciated risk factor?. Strahlenther Onkol 2009; 185: 663-668
- 52 Hennequin C, Bossard N, Servagi-Vernat S. et al Ten-year survival results of a randomized trial on irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 2013; 86: 860-866 Int J Radiat Oncol Biol Phys. 2014 Aug 1; 89(5):1145
- 53 Poortmans PM, Collette S, Kirkove C. et al EORTC Radiation Oncology and Breast Cancer Groups Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med 2015; 373 (04) 317-27
- 54 Whelan TJ, Olivotto IA, Parulekar WR. et al. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med 2015; 373 (04) 307-16
- 55 Thorsen LB, Offersen BV, Danø H. et al. A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J J Clin Oncol 2016; 34 (04) 314-20
- 56 Wapnir IL, Price KN, Anderson SJ. et al. Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. J Clin Oncol 2018; 36: 1073-1079
- 57 Aebi S, Gelber S, Anderson SJ. et al. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol 2014; 15: 156-163
- 58 Harms W, Geretschlager A, Cescato C. et al. Current Treatment of Isolated Locoregional Breast Cancer Recurrences. Breast Care (Basel) 2015; 10: 265-271
- 59 Waeber M, Castiglione-Gertsch M, Dietrich D. et al. Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Ann Oncol 2003; 14: 1215-1221
- 60 Cai G, Cao L, Kirova YM. et al. Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer. Radiat Oncol 2019; 14: 115
- 61 Semrau S, Gerber B, Reimer T. et al. Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysis. Strahlenther Onkol 2006; 182: 596-603
- 62 Yang K, Kim H, Choi DH. et al. Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer. Radiat Oncol 2020; 15: 16
- 63 Wadasadawala T, Vadgaonkar R, Bajpai J. Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities. Clin Breast Cancer 2017; 17: 493-502